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Introduction
Alzheimer's disease (AD) is an age-related neurodegenerative disease. Over 95% of AD cases are sporadic with unknown etiology (Masters et al., 2015) . Extracellular β-amyloid (Aβ) depositions and neurofibrillary tangles are the neuropathological hallmarks of AD. Aβ accumulation induces neurotoxicity, neuroinflammation, and synaptic dysfunction, all of which play pivotal roles in AD pathophysiology (Heneka et al., 2015; Sakono and Zako, 2010) .
Systemic insulin signaling plays a role in nutrient metabolism. Insulin may preserve brain function and structure in the central nervous system (CNS).
Furthermore, insulin resistance may be a pathogenic factor for AD (De Felice et al., 2014; de la Monte, 2017; Spielman et al., 2014) . This line of inquiry is currently under intensive investigation (Frazier et al., 2019; Lyra et al., 2019) . Inflammation and impaired insulin signaling, which is associated with type 2 diabetes, is also likely to promote AD pathology (Baglietto-Vargas et al., 2016; De Felice et al., 2014) .
Disruptions to brain glucose utilization and metabolic hormones are considered to be key elements in AD pathophysiology (Bonda et al., 2014) .
Leptin secreted by white adipose tissue acts on the hypothalamus and brainstem to regulate energy homeostasis (Caron et al., 2018) . Leptin receptors are abundantly expressed in the hypothalamic appetite control nuclei, including the arcuate nucleus (ARC), the dorsomedial hypothalamus (DMH), and the ventromedial hypothalamus (VMH) (van Swieten et al., 2014; Zhang et al., 2015) . Leptin induces phosphorylation of signal transducer and activator of transcription 3 (STAT3). Phosphorylated STAT3 (pSTAT3) upregulates proopiomelanocortin (POMC) gene and downregulates Agoutirelated protein (AgRP), and neuropeptide Y (NPY) genes, which are involved in the appetite control.
In addition to cognitive symptoms, AD is also associated with non-cognitive symptoms, which include alterations in hypothalamus-mediated feeding behaviors and body weight; these changes often precede cognitive impairments (Hiller and Ishii, 2018; Ishii and Iadecola, 2015) . Notably, 3xTg AD mice are less sensitive to cholecystokinin, a satiety factor, and have a decrease in the neuronal activity that modulates feeding behaviors (Adebakin et al., 2012) . The non-cognitive AD symptoms resulting from hypothalamic dysfunction are observed in AD patients (Hiller and Ishii, 2018) and experimental AD transgenic mouse models (Do et al., 2018) ; however, the mechanism mediating hypothalamic dysfunction in AD is unclear.
Our previous studies have suggested that reciprocal augmentation between highfat diet (HFD)-induced metabolic stress and AD central pathogenesis accelerates cognitive impairment and fatty liver disease in HFD-fed APP/PS1d9E (APP/PS1) transgenic mice Shie et al., 2015; Yeh et al., 2015) . Like HFD, the use of sugars and high-fructose corn syrup in the modern western diet contributes to the epidemic of obesity and metabolic disorders Hannou et al., 2018; Malik et al., 2010; Mortera et al., 2019) . High-sucrose diets (HSD) have been shown to induce hyperglycemia, hyperinsulinemia, and fatty liver disease without increasing food intake and body mass in wild-type (WT) mice (Flister et al., 2018; Oliveira et al., 2014) and rats (Seshadri et al., 2019) . Administration of sucrosesweetened water induces a pre-diabetes stage in WT mice that includes glucose intolerance and hyperglycemia, which are followed by compensation via hyperinsulinemia and insulin resistance, but without the development of obesity (Burgeiro et al., 2017) . Intake of sucrose-sweetened water induces peripheral insulin resistance, accelerates memory deficits, and promotes amyloidosis in APP/PS1 mice (Cao et al., 2007; Orr et al., 2014) . To date, no study has evaluated the impact of HSD on AD pathology. To compare the effects of HSD with those of normal chow diet, we used HSD pellet instead of sucrose-sweetened water.
This study evaluated whether HSD affects AD-related pathology and hypothalamic functionality. The body weight, glycemic regulation, neuroinflammation, and hypothalamic leptin signaling of HSD-fed WT and APP/PS1 mice were compared. The cognitive and non-cognitive behaviors of WT and APP/PS1 mice fed either a normal chow diet (NCD) or HSD were investigated. Our findings reveal the deleterious effects of HSD on AD pathogenesis and they provide novel insights into the role of leptin resistance on the non-cognitive symptoms of AD.
Materials and Methods

Animals
All animal handling procedures were approved by the Yang-Ming University Institutional Animal Care and Use Committee (IACUC No: 1041251, 30, Dec., 2015) . APP/PS1 transgenic mice (B6.Cg-Tg[APPswe,PSEN1dE9]85Dbo/Mmjax; No. 005864) expressing a chimeric mouse/human APP695 that harbored Swedish K595N/M596L mutations (APPswe) and human PS1 with the exon-9 deletion mutation (PS1dE9) were purchased from the Mutant Mouse Resource and Research Center at the Jackson Laboratories and bred in-house. Mice were provided with food and water ad libitum and were housed under controlled room temperature (22 ± 2˚C) and humidity (55-65%) under a 12:12 h light-dark cycle. The dark cycle lasted from 19:00-7:00. Non-alcoholic fatty liver disease (NAFLD) is a sexually dimorphic disease (Ballestri et al., 2017; Pape et al., 2018) . Previously we found that high-fat diet-induced NAFLD in APP/PS1 mice does not occur in female mice . The purpose of our present study was to create an animal model of NAFLD-like metabolic stress using HSD. Therefore, only male mice were used. More than three cohorts of male APP/PS1 mice and their WT littermates were randomly assigned to the various dietary manipulation groups at 10 weeks old. One group were fed NCD containing carbohydrates at 50.0%, fat at 5.0%, and sucrose at 1.16% by weight (5010, Lab Diet, USA) . These mice were designated as NCD WT and NCD APP/PS1 groups, respectively. The other groups were fed HSD containing carbohydrate at 67.3%, fat at 4.3%, and sucrose at 35% by weight (D12450B, Research Diet, USA), respectively. These mice were designated as HSD WT and HSD APP/PS1 groups. Fat content was comparable in the NCD and the HSD, and the major difference between the NCD and the HSD was the sucrose content.
Measurements of serum biochemical parameters
Blood samples were collected from the tail vein of male NCD WT, NCD APP/PS1, HSD WT, and HSD APP/PS1 mice to measure levels of leptin and soluble leptin receptor (LepRs) after a 16-h (18:00 to 10:00) fasting at 6, 12, 20, and 28 weeks of dietary manipulation . A 4-h (10:00-14:00) refeeding was performed after 16-h fasting (18:00 to 10:00) after 20 weeks of dietary manipulation.
The levels of leptin and LepRs were measured using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minnesota, USA). The fluorescence intensity was measured at 450 nm.
Measurement of cortical and serum Aβ and IL-6
The levels of cortical Aβ40 and Aβ42 after 28 weeks of dietary manipulations were measured as previously described . The cerebral cortex was homogenized into phosphate buffer saline (PBS) containing 0.5% SDS, 0.5% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride with protease inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN, USA). Following sonication and centrifugation, the supernatant was designated as the SDS-soluble fraction. The pellet was suspended in 3 M guanidine-HCl and sonicated. Following centrifugation, the supernatant was designated as the SDS-insoluble fraction. The levels of Aβ40 and Aβ42 in cerebral cortex and serum were measured using Aβ ELISA kits (Invitrogen, CA). The serum levels of interleukin 6 (IL-6) were measured by ELISA according to the manufacturer's instructions (R&D Systems, Minnesota, MN) at a sensitivity of 7 pg/ml.
Leptin-induced feeding suppression
Singly housed mice from each group were acclimated with a food container (Oriental Yeast Co., Ltd., Japan) for one week. The daily food intake was recorded using a food container over the first three days after the dietary switch and after 23 weeks of dietary manipulation. Leptin-induced feeding suppression of HSD WT and APP/PS1 mice after 28 weeks of dietary manipulation was performed as previously described with minor modifications (Tillman et al., 2014) . Briefly, mice were injected intraperitoneally with mouse recombinant leptin (R&D Systems, Minnesota, USA) at a dose of either 4 mg/kg leptin or PBS at 18:30. Food pellets in a food container were provided at the beginning of the dark cycle (19:00) and after 4, 8, and 12 h the cumulated food intake was measured.
Assessment of locomotor activity and daily living capability
Assessment consisting of the open field test, nesting, burrowing, and marble burying were performed after 26-27 weeks of dietary manipulation. The open field test was performed as described previously . Mice were placed in a plastic box (40 cm × 40 cm × 38 cm) and allowed to explore freely for 30 min (19:00 to 19:30). Data were analyzed by EthoVision video tracking system (Noldus Information Technology, Netherlands). To record nesting behavior, mice were housed individually with two pieces of Nestlet (Ancare, UK agent, Lillico) as described previously . After 16 h, the constructed nest was scored from 1-5 according to Deacon's system (Deacon, 2006) and the unshredded Nestlet was weighed. The time to complete the nest (rating score 5) was recorded. Marble burying was performed as described previously (Thomas et al., 2009) . Mice were allowed to freely explore a cage containing marbles for 30 min and then the number of marbles buried was counted. The burrowing test was performed as described previously (Tzeng et al., 2018) . Mice were housed individually and allowed to habituate for 24 h.
The burrowing devices were filled with 230 g food pellets and placed into cages. The amount of food pellets left in the burrows was recorded after 2 hours.
Food entrainment test
The food entrainment test was performed as described previously with some modifications (Mieda et al., 2006) . A schematic diagram of the food entrainment test is shown in Fig. 5A . Briefly, male APP/PS1 and WT mice that had been fed either NCD or HSD were singly housed at 24 weeks after dietary manipulation. Two NCD or HSD food pellets were placed on the cage floor and replaced with fresh food every day at 11:00 for three days; this was designated as ad libitum feeding (ALF) period.
The home-cage mobility of was recorded mice for 24 h on the day 3 of ALF period.
The next day, two food pellets were put on cage floor at 11:00 and then the leftover food was removed at 15:00 for 9 days; this was designated the restricted feeding (RF) period. The home-cage mobility was recorded for 24 h on the day 9 of RF. On day 10, the mice were given no food; this was designated the no food (NF) period. The mobility of mice on the day of NF was also recorded for 24 h.
Immunohistochemical and histochemical staining
After 28 weeks of dietary manipulation, mice from the various groups were perfused with 4% paraformaldehyde, and their brain tissues were cryoprotected. Freefloating brain sections (Bregma: -1.72 to -2.20) were incubated with mouse antiphosphorylated STAT3 (pSTAT3) (1:1000, Sigma) overnight at 4°C. After washes, the brain sections were incubated with biotinylated secondary antibodies (1:1000, Sigma) for 2 h at room temperature. The sections were then washed with 1X Tris-buffered saline and incubated with ABC reagent. Next, the DAB coloring reaction was performed. Areas identified as the ARC, VMH, and DMH were defined by the presence of clustered nuclei stained with DAPI or Neutral Red prior to pSTAT3 immunohistochemical staining. The numbers of pSTAT3-positive cells were quantified using ImageJ software (the National Institutes of Health, USA) after converting the color images to grayscale. The cells with pSTAT3 intensity above the 0-100 threshold setting in ImageJ software were counted as pSTAT3-positive cells as described previously . Finally, a visual inspection of each brain slice was carried out to confirm that the cells counted by ImageJ were pSTAT3-positive.
The numbers of pSTAT3-positive cells present in two to three sequential slices were averaged. To detect double staining of senile plaques and astrocytes, brain sections were stained with Amylo-Glo RTD amyloid staining reagent (1:100, Biosensis) and then were washed in PBS with Tween-20. Next, the brain slices were incubated with mouse anti-glial fibrillary acidic protein (GFAP) antibody (1:5000, Sigma) at 4°C overnight. After washes, the brain slices were incubated with donkey anti-mouse Alexa Fluor ® 594 secondary antibody (1:500, Alexa). After washes, the sections were mounted in Aqua Poly/Mount (Polyscience Inc, PA, USA) and images were captured using Zeiss Axioplan 2 microscope. The coverage of senile plaques and GFAP fluorescent intensity were quantified using ImageJ.
RNA extraction and real-time PCR
After 28 weeks of dietary manipulation, the cortex of one hemisphere from mice of the four groups and the whole hypothalamus from mice of HDF groups were homogenized in TRIzol reagent and total RNA was prepared (Invitrogen, Camarillo, CA). RNA (2-5 µg). Each RNA sample was reverse transcribed into cDNA using Table I .
Accurately aligned whole-body anatomical micro-computed tomography for fat mass comparison
Mice were anesthetized using isoflurane after 6, 10, and 20 weeks of dietary manipulation. Images were acquired using micro-computed tomography (MILabs, Utrecht, Netherlands). The range of images in length was 79.5 mm, and mice were imaged using 480 projections. The X-ray parameters were set at 0.48 mA and 50 kV.
Finally, an image voxel was constructed using 80 µm. The images were analyzed using PMOD 3.8 (PMOD Technologies LTD, Zurich, Switzerland). The image matrix was reduced by 2×2×2 at first, and segmented into different body compositions according to tissue density. The threshold for fat tissue was -400 ~ -200 HU. After acquiring the volumes in voxels in cm 3 for fat tissue, the amount of body fat was presented in grams and then the percentage of fat mass of the four groups were calculated.
Statistical Analysis
Statistics were performed using GraphPad Prism 6 (GraphPad, CA, USA). All values are given as means ± standard error of the mean (SEM). All experiments were performed more than three times. Comparisons between two groups were carried out using an unpaired Student's t-test. To compare multiparametric analysis, one-way analysis of variance (ANOVA) followed by Bonferroni post-hoc analysis. Two-way ANOVA (general linear model) were used to analyze the interaction between dietary manipulation and genotype for the biochemical indices, leptin-induced pSTAT3 upregulation, and the multiple behavioral tests; the results are shown in Tables II-IV. Nonparametric statistical tests (Kruskal-Wallis test followed by Dunn's multiple comparison test) was used for the score of nesting. A p value less than 0.05 was considered to show a significant difference.
Results
The level of neuroinflammation of high-sucrose diet-fed APP/PS1 mice is elevated
The impact of a high-sucrose diet (HSD) on AD pathogenesis was assessed by comparing the senile plaque burden and glial activation between normal chow diet (NCD)-fed WT and APP/PS1 mice (designated as NCD WT and NCD APP/PS1 groups) and HSD-fed WT and APP/PS1 mice (designated as HSD WT and HSD APP/PS1 groups) after 28 weeks of dietary manipulation. Amylo-Glo RTD amyloid staining reagent was used to detect senile plaques; anti-GFAP antibody was used to detect reactive astrocytes. The fluorescent images showed that activated astrocytes clustered at the foci of the senile plaques in the cortices of NCD and HSD APP/PS1 mice (Fig. 1A) . The expression of GFAP was low and senile plaques were not detected in the cortices of NCD and HSD WT mice. The coverage of senile plaques in NCD and HSD APP/PS1 mice was not different (data not shown). The ratio of GFAP coverage and senile plaque coverage of HSD APP/PS1 mice was marginally, but not significantly, higher than that of NCD APP/PS1 mice (F (1, 9) = 4.984, p = 0.108) ( Fig.   1 B) . The ratio of GFAP intensity and senile plaque coverage of HSD APP/PS1 mice was not significantly higher than that of NCD APP/PS1 mice (F (1, 9) =3.357, p = 0.199) ( Fig. 1 C) . The ratio of GFAP coverage and GFAP intensity vs. senile plaque coverage shows a trend towards elevation in HSD APP/PS1 mice, and therefore the expression levels of GFAP and inflammatory cytokines were compared by RT-PCR ( Fig. 1D -G).
The cortical mRNA levels of GFAP and interleukin 1β (IL-1β) genes of HSD APP/PS1 mice were higher than those of NCD APP/PS1 and HSD WT mice ( Fig. 1D , E). The cortical mRNA level of ionized calcium binding adaptor molecule 1 (Iba-I) in HSD APP/PS1 mice was higher than in HSD WT ( Fig. 1F ). However, the cortical mRNA level of IL-6 did not differ across the four groups ( Fig. 1G ).
Next, ELISA was performed to quantify the levels of Aβ of four groups after 28 weeks of dietary manipulation. The cortical levels of SDS-soluble and SDS-insoluble Aβ40 and Aβ42 were significantly increased in HSD APP/PS1 mice compared with NCD APP/PS1 mice ( Fig. 1H , I). As expected, Aβ40 and Aβ42 were not detected in NCD WT and HSD WT mice. Soluble Aβ present in peripheral circulation has been shown to induce systematic glucose dysregulation and insulin insensitivity of the liver (Bomfim et al., 2012; Zhang et al., 2013) , and then we next examined the serum levels of Aβ and interleukin 6 (IL-6) after 28 weeks of dietary manipulation. Serum
Aβ was significantly elevated in HSD APP/PS1 mice compared with NCD APP/PS1 mice ( Fig. 1J ).
Serum IL-6 was undetectable in NCD WT mice ( Fig. 1 K) . Furthermore, the level of serum IL-6 present in HSD APP/PS1 mice was higher than that of HSD WT mice. These findings suggest that both peripheral inflammation status and central neuroinflammation were exacerbated in HSD APP/PS1 mice. In addition, pSTAT3positive cells were detected in the cortices of APP/PS1 mice (supplemental fig. 1 ), and this has been shown to be mediated by IL-6 (Kim et al., 2016) . No pSTAT3positive cells were detected in the cortices of WT groups. The pSTAT3-positive cells were also present in the hippocampus of APP/PS1 mice, but not in hippocampus of WT groups (data not shown). Our data indicated that HSD and AD pathology augments inflammation and Aβ levels in the CNS and periphery. Two-way ANOVA indicated that HSD interacts with APP/PS1 genetic background on the upregulation of GFAP and IL-1β mRNA in the mouse cortex (Table II) .
A high-sucrose diet increases fat mass prior to increasing body weight.
Previous studies have shown that insulin resistance can be induced by HSD in WT rodents (Apolzan and Harris, 2013; Oliveira et al., 2014; Schultz et al., 2015) and by sucrose-sweetened water in 3XTg AD mice (Orr et al., 2014) . Whether or not glucose homeostasis in APP/PS1 mice is altered by HSD was assessed in this study.
The glucose levels between four groups were not different after 6-7 weeks of dietary manipulation (supplemental fig. 2 ). However, after 12 weeks of dietary manipulation, the glucose levels of HSD groups were significantly higher than that of NCD groups.
The insulin levels of HSD APP/PS1 mice were elevated, whereas the glucose levels of HSD WT and HSD APP/PS1 mice were comparable ( Fig. 2A, B) . The HOMA-IR results, which acts as an indirect measure of insulin resistance, suggested that insulin resistance was higher in HSD APP/PS1 mice (Fig. 2C ).
The body weight between the four groups was not different after 20 weeks of dietary manipulation. Over that time, however, there was a trend towards weight gain in HSD groups. The body weights of HSD groups were significantly higher than that of NCD groups after 24 weeks of dietary manipulation (Fig. 2D ). However, the body weights were not different between HSD APP/PS1 and WT mice. Whether excess food intake was induced by HSD was examined. HSD did not induce a higher daily energy intake in the first three days after the dietary switch ( Fig. 2E ). The daily energy intake of the four groups was not different after 23 weeks of dietary manipulation, even though a trend towards weight gain in HSD groups compared to NCD groups could be observed between 20 to 24 weeks ( Fig. 2F ). This data indicates that the weight gain in HSD groups was not caused by hyperphagia. Our findings suggest that glycemic dysregulation is an earlier biomarker than body weight gain induced by HSD in APP/PS1 mice.
To determine whether the APP/PS1 genetic background or HSD alters lipogenesis, the body fat mass of the four groups was measured by micro-computed tomography. No difference was found in the fat mass of the four groups after 6 and 10 weeks of dietary manipulations (data not shown). Nevertheless, the fat mass of HSD groups, especially the visceral fat, was significantly greater than that of NCD groups after 20 weeks of dietary manipulation, as shown by the micro-computed tomography ( Fig. 2G ). One-way ANOVA suggested that HSD significantly increases fat mass compared to NCD in both WT and APP/PS1 mice prior to body weight differences between NCD and HSD groups (Fig. 2 H) . Two-way ANOVA indicated that both HSD and APP/PS1 genetic background had main effects on insulin levels, HOMA-IR, and body weight. Only HSD had a main effect on fat mass.
Leptin resistance of HSD groups is induced in the absence of hyperleptinemia.
The body weight and fat mass of HSD groups are higher than those of NCD groups, and therefore whether HSD induces hyperleptinemia was then assessed.
Although the fat mass of HSD groups was higher than that of NCD groups, the fasting levels of leptin were not different among the four groups, and after dietary manipulation for 6 weeks: F (1, 32) = 3.149, p = 0.0684, after dietary manipulation for 12 weeks: F (1, 32) = 2.557, p = 0.0725; and after dietary manipulation for 28 weeks: F (1, 32) = 0.157, p = 0.6764 (Fig. 3A) .
LepRs released by the liver are able to bind to leptin and reduce the level of effective leptin in the bloodstream (Schulz and Widmaier, 2006) . Therefore, we investigated whether HSD regulates the serum levels of LepRs. The level of fasting LepRs of HSD WT mice was higher than that of NCD WT mice after 6, 12, and 28 weeks of dietary manipulation (Fig. 3B ). The level of fasting LepRs of HSD APP/PS1 mice was higher than that of NCD APP/PS1 mice only after 28 weeks of dietary manipulation. These findings suggest that a higher level of free leptin was available for transport into the CNS of in HSD APP/PS1 mice compared to HSD WT mice after 6, and 12 weeks of dietary manipulation.
Fasting acts as a signal to the body that energy stores need to be replenished. The serum level of leptin and LepRs in response to refeeding after a 16-h fast was examined after 20 weeks of dietary manipulation in order to assess the response of adipose tissue and liver to an altered energy status when the body weight of four groups was not different (Knights et al., 2014) . The level of leptin of the four groups was decreased in response to a 16-h fast (Fig. 3C) . The leptin levels of NCD groups after refeeding were similar to non-fasting levels, suggesting that the release of leptin by white adipose tissues of NCD groups was similar during refeeding and non-fasting.
However, the leptin level of HSD groups was significantly higher than that of NCD groups after refeeding. This result suggests that the white adipose tissue of HSD groups release greater amounts of leptin in response to energy replenishment.
The level of LepRs in HSD groups was higher than that of NCD groups during non-fasting, fasting, and refeeding. This result suggests that the livers of HSD groups released more LepRs that then bind to leptin in circulation compared to NCD groups (Fig. 3D) . The level of LepRs in HSD WT mice was higher than in HSD APP/PS1 mice during non-fasting and fasting, but not during refeeding. Therefore, refeeding elevated the levels of leptin and LepRs in HSD WT and APP/PS1 APP/PS1 mice equally. This suggests that the liver and adipose tissue of HSD APP/PS1 mice functioned as well as those of HSD WT mice during energy replenishment ( Fig. 3 C,   D ). Taken together with the increased body weight and the greater fat mass of HSD groups, the higher leptin levels induced by refeeding in HSD groups prompted us to examine whether leptin sensitivity was altered by HSD after 28 weeks of dietary manipulation. Leptin was intraperitoneally injected once into mice in each of the four groups and food intake was measured at 4, 8, and 12 hours after refeeding (Fig. 3E ).
The cumulative food intake of NCD groups was reduced by leptin. However, the food intake of HSD groups was not different with or without the leptin injection. These findings suggest that leptin sensitivity was reduced in HSD groups.
Two-way ANOVA showed that HSD interacted with APP/PS1 genetic background at the level of non-fasting LepRs and fasting LepRs ( Table. II ).
Furthermore, HSD had a main effect on the levels of leptin and soluble leptin receptor after refeeding.
Leptin signaling is attenuated at the VMH and DMH of HSD APP/PS1 mice
Senile plaques and GFAP upregulation in the hypothalamus of APP/PS1 mice was not detected by Amylo-Glo staining and GFAP immunohistochemistry staining, respectively, after 28 weeks of dietary manipulation (supplemental fig. 3A ). However, leptin sensitivity is attenuated by HSD, and therefore we examined whether leptin signaling in the hypothalamus is different for HSD WT and APP/PS1 mice by comparing the number of pSTAT3-positive cells in the mediobasal hypothalamus (MBH) of HSD groups after injection with either leptin or vehicle (PBS) (Fig. 4A ).
Initially the specificity of anti-pSTAT3 antibody was examined by using alkaline phosphatase to eliminate the immunohistochemical signal of pSTAT3 (supplemental fig. 4A ). In addition, the nuclear compartmentalization of pSTAT3 after leptin injection was confirmed by confocal imaging in the hypothalamus (supplemental fig.   4B , C). Leptin-induced pSTAT3 in the hypothalamus of WT and APP/PS1 mice was quantified after 28 weeks on HSD. The level of leptin-induced pSTAT3 in the ARC was similar to that found in HSD APP/PS1 and WT mice (Fig. 4B) . Nevertheless, the level of leptin-induced pSTAT3 in the VMH and DMH of HSD APP/PS1 mice was attenuated compared to that of HSD WT mice (Fig. 4C, D) .
Next, we examined whether the mRNA levels of leptin downstream genes that mediate satiety were altered by HSD in the hypothalamus. The mRNA expression levels of AgRP and POMC genes were found to be upregulated by HSD in the hypothalamus of WT mice, but not in the hypothalamus of APP/PS1 mice (Fig. 4E,   F ). Our results suggest that there is differential regulation of these leptin downstream genes between WT and APP/PS1 mice in the hypothalamus after 28 weeks on HSD.
However, the mRNA expression levels of NPY, Suppressor of cytokine signaling 3 (SOCS3), GFAP, and Iba-1 were found not to be different when these four groups were compared (supplemental fig. 3B-E) . Therefore, HSD attenuated leptin signaling in APP/PS1 mice, including a reduction of hypothalamic pSTAT3-positive cells and the leptin downstream target genes and that this occurs prior to the presence of senile plaques and astrocyte activation.
Two-way ANOVA showed that leptin treatment interacted with APP/PS1 genetic background with respect to the number of pSTAT3-positive cells in the VMH and DMH after 28 weeks on HSD (Table III) . HSD interacted with APP/PS1 genetic background on mRNA level of POMC gene in the hypothalamus. HSD had a main effect on mRNA levels of AgRP and SOCS3 genes (Table II) . Furthermore, APP/PS1 genetic background had a main effect on mRNA level of Iba-1.
The food-anticipation activity is impaired in HSD APP/PS1 mice
It has been suggested that the DMH modulates the wakefulness and foodanticipation activity of the food-entrainable circadian (Mieda et al., 2006; Tahara and Shibata, 2013) . The attenuated leptin signaling in the DMH of HSD APP/PS1 mice prompted us to investigate whether the food anticipation activity of HSD APP/PS1 mice was altered after 23 weeks of dietary manipulation. The experimental design is shown in Fig 5A. During food-restricted training (RF), food pellets were provided from 11:00-15:00 in the light phase. After 9 days of RF, no food pellets were provided during the following day (NF). The distance traveled in 24 h was measured on the ALF day, the 9 th day of RF, and the NF day (Fig. B-D) . Locomotion was induced prior to the feeding period on the 9 th day of RF and the NF day (Fig. 5C, D) . The total distances traveled by the four groups from 7:00-15:00 during the ALF day, the 9 th day of RF, and the NF day were compared. The travel distance between the four groups was not different during the ALF day from 7:00-15:00 (Fig. 5E ). On the 9 th day of RF training, the travel distance of HSD groups from 7:00-15:00 was significantly lower than that of NCD groups, suggesting that the anticipatory activity of HSD groups was reduced ( Fig. 5F ). On the NF day, the distance traveled from 7:00-15:00 by HSD APP/PS1 mice was the lowest of the four groups, suggesting that the anticipatory activity related to food availability of HSD APP/PS1 mice was further attenuated compared to the other three groups (Fig. 5G ). Statistically similar results were obtained for the distance traveled from 7:00-19:00 by the four groups during the ALF day, the 9 th day of RF, and the NF day (supplemental fig. 5A-C) .
The distance traveled in the critical time period spanning 2 h before and 2 h after the feeding time on the NF day was further analyzed. Consistently, the distance traveled by HSD APP/PS1 mice in the four time periods (9:00 to 10:00, 9:00 to 11:00, 9:00 to 12:00, and 9:00 to 13:00) was lower than that of NCD APP/PS1 mice on the NF day (Fig. 5H ). However, no difference in the distance traveled between NCD WT and HSD WT mice was observed for any time period.
There was no difference in the locomotor activity during the dark cycle (19:00 to 7:00) between the four groups on the ALF, RF, and NF days, which suggests that the overall locomotor activity of the four groups was similar (supplemental fig. 5D -F). Consistently, the hourly locomotor activity during the dark cycle on the NF day was not significantly different between the four groups (supplemental fig. 5G ). Therefore, the reduced travel distance of HSD APP/PS1 mice from 7:00-15:00 on the NF day was not due to a general attenuation of locomotor activity. Two-way ANOVA showed that HSD interacted with APP/PS1 genetic background for the travel distance on the NF day, and that both HSD and APP/PS1 genetic background had simple main effects (Table IV) .
HSD and APP/PS1 genetic background affect the ability to construct nests and burrow
In addition to an attenuation of locomotion on the RF and NF days by HSD APP/PS1 mice, motor activity, anxiety, and cognition behaviors were also evaluated to determine whether HSD altered the mobility, anxiety and cognitive functions of APP/PS1 and WT mice at 26-27 weeks after dietary manipulation. The total movement distance, duration in the center zone, and the frequency of center crossing of four groups in the open field test were comparable, and the results suggested that the motor activity and anxiety of HSD groups were not different to those of NCD groups ( Fig. 6A-C) . The number of marbles buried by HSDWT mice was significantly lower than that of NCD WT mice, while the number of marbles buried by HSD APP/PS1 mice was not different from that of NCD APP/PS1 mice (Fig. 6D) .
The marble burying, one of anxiety measurements, revealed that anxiety level of HSD WT mice was lower than that of NCD WT mice, but that there was no difference for APP/PS1 groups.
Nesting and burrowing tasks were used to evaluate the impact of HSD and AD pathology on cognition and daily living capability. The nest score of NCD WT mice was higher than that of HSD WT mice, however, no difference was observed between that of NCD WT and NCD APP/PS1 mice. Furthermore, the nest score of HSD WT mice was not different from that of HSD APP/PS1 mice (Fig. 6E) . The nest completion time of HSDAPP/PS1 group was longer than that of HSDWT group (Fig.   6G ). No differences between NCD and HSD APP/PS1 mice in the nest scores, unshredded Nestlet weight, and nest completion time, which suggests that the cognition of NCD APP/PS1 mice after 26-27 weeks of dietary manipulation (when the mice were 36-37 weeks old) was already impaired (Fig. 6E-G) . The weight of food pellets burrowed by for HSD APP/PS1 mice was less than that of NCD APP/PS1 mice, which suggests that the daily living capability of APP/PS1 mice was hindered by HSD ( Fig. 6H) . Two-way ANOVA showed that HSD and APP/PS1 genetic background did not interact with each other, but that both had a main effect on marble burying and nesting behaviors (Table IV) .
Discussion
The impact of HSD on hypothalamus-mediated energy homeostasis has not been well studied compared to the effects of HFD; this is possibly because of the absence of obesity or the presence of only minor weight gains among the model animals (Flister et al., 2018) . Furthermore, the hypothalamus-involved non-cognitive symptoms of HSD APP/PS1 mice remain largely unexplored. Our findings suggest that HSD induces a mild weight gain and that there is exacerbation of glycemic dysregulation among APP/PS1 mice. We have further demonstrated that HSD attenuates leptin signaling in the DMH and VMH of APP/PS1 mice and alters their food-anticipatory activity. Our study is the first to suggest that HSD is able to differentially affect leptin signaling in the hypothalamic nuclei of APP/PS1 and WT mice.
The insulin resistance and increased Aβ burden of AD transgenic mice has been induced by sucrose-sweetened water (Cao et al., 2007; Orr et al., 2014) . In this study, HSD solid food pellets were used to feed APP/PS1 mice and these contain relatively lower amounts of sucrose compared to the HSDs used to feed WT mice in previous studies. Our findings suggest that HSD interacts with APP/PS1 genetic background on the upregulation of GFAP and IL1β and increases neuroinflammation.
Furthermore, elevated serum IL6, which can be released by enlarged visceral adipose tissue in HSD APP/PS1 mice, may also contribute to peripheral insulin resistance .
Both HSD-fed rodents and high fructose-fed rats have a higher body fat content and reduced leptin effectiveness (Bray, 2004; Harris, 2018; Oliveira et al., 2014) .
Only one report has shown that a high-fructose diet attenuated leptin-induced feeding suppression and hypothalamic pSTAT3 induction in WT rats; however, pSTAT3 activity in individual hypothalamic nuclei was not investigated (Shapiro et al., 2008) .
Our work is the first to demonstrate that HSD APP/PS1 mice had attenuated leptininduced pSTAT3 in the VMH and DMH but not in the ARC.
In our previous study, we compared the number of leptin-induced pSTAT3positive cells in NCD WT and NCD APP/PS1 mice . The results showed that leptin-induced pSTAT3 expression was similar in the ARCs, VMHs, or DMHs of NCD WT and APP/PS1 mice. In the present study, our results indicate that leptin-induced pSTAT3 expression is significantly lower in the VMH and DMH, but not in the ARC of HSD APP/PS1 mice than of HSD WT mice. Two-way ANOVA showed that the decrease in leptin-induced pSTAT3 in HSD APP/PS1 mice vs.
HSDWT mice is due to the interaction of APP/PS1 genetic background and HSD.
In addition to roles in energy homeostasis, the DMH is involved in modulating food-entrainable circadian rhythms and the VMH is essential for systemic glycemic regulation (Gooley et al., 2006; Shimazu and Minokoshi, 2017) . The glycemic dysregulation observed in HSD APP/PS1 mice during our study may be associated with reduced leptin signaling in the VMH. The DMH is required to anticipate the feeding times of wake-sleep and locomotion during RF (Saper, 2013) . Food anticipation was found to be normal for NCD APP/PS1 mice, which is consistent with the previous study during which food anticipation was normal for APP/PS1 mice fed regular chow (Kent et al., 2019) . We report here that HSD APP/PS1 mice show altered food-entrainable circadian rhythms that may contribute to the non-cognitive symptoms of AD. This altered feeding behavior may be associated with an attenuation of leptin signaling in the DMH. However, the involvement of DMH in foodanticipatory activity remains controversial (Landry et al., 2006 (Landry et al., , 2007 (Landry et al., , 2011 Moriya et al., 2009 ). In addition, two studies have shown that a loss of leptin signaling is associated with increased food anticipation in rat and mice (Mistlberger and Marchant, 1999; Ribeiro et al., 2011) . Therefore, it is possible that the HSDalterations in the food-entrainable circadian rhythms of APP/PS1 mice may be mediated by other pathways with or without the involvement of attenuated leptin signaling in the DMH.
The major difference between food-anticipatory activity on the day 9 th of RF and the NF day is that a decrease in food-anticipatory activity was found for HSD WT mice compared to NCD WT mice on the 9 th day of RF, but this was not the case for the NF day. One interpretation of this result is that there is HSD impaired foodanticipatory activity in both WT and APP/PS1 mice, but that the memory of foodentrained behavior is impaired in HSD APP/PS1 mice, but not in HSD WT mice.
Although senile plaques and mRNA upregulation of GFAP and Iba-1 genes were not detected in the hypothalamus, elevated neuroinflammation in the cortex and hippocampus of HSD APP/PS1 mice may have had an effect on hypothalamic functioning via the interconnected limbic system Yeh et al., 2015) . A recent study has indicated that an increase in stalled blood flow in the cortical capillaries of APP/PS1 and 5xFAD mice relative to WT mice brings about an impairment of memory functions (Cruz Hernandez et al., 2019) . Therefore, ADrelated pathology in the cortex and hippocampus is likely to hinder neuronal functioning via the limbic system. Upregulation of NPY and downregulation of POMC have been observed previously in HFD-induced obesity groups compared to diet resistant groups (Cifani et al., 2015) . Furthermore, the transcriptional regulation of NPY and POMC genes is inversely correlated with DNA methylation of the promoter regions of NPY and POMC genes of the HFD-induced obesity groups. In the present study, the mRNA levels of AgRP and POMC genes were found to be upregulated in the hypothalamus of HSD WT mice, but this was not the case for HSD APP/PS1 mice. In our previous study, hyperphagia was found to be induced in the first two days after the dietary switch and after 23 weeks on HFD . In contrast, hyperphagia was not induced by HSD in the present study. Up to the present no study has revealed an effect of HSD on the mRNA expression of NPY and POMC genes in the hypothalamus, and therefore the impact of the changes in the expression profiles of AgRP and POMC genes in response to HSD on the energy homeostasis of WT and APP/PS1 mice is not clear.
The role of hypothalamic microglial activation in HFD-induced obesity is well established (Valdearcos et al., 2018) . However, whether HSD induces the activation of hypothalamic microglia remains unstudied. Using a diet containing high sucrose and high fat, Gao et.al. have shown that microgliosis and astrogliosis in the arcuate nucleus are enhanced (Gao et al., 2017) . In their study, hypothalamic neuroinflammation was induced by the interaction between a high fat content and a high sucrose content. Nevertheless, we did not observe any difference in the expression of Iba-1 and GFAP in the hypothalamus of the four groups. The fat content of HSD used in our study is comparable to that found in NCD we used. Therefore, the discrepancy between our results and theirs may be due to the significant difference in fat content between the diets as well as the difference in treatment durations.
In conclusion, high sucrose consumption from solid pellets accelerates insulin intolerance, induces feeding behavior abnormalities, increases cortical and serum levels of Aβ, and causes inflammation within the CNS and peripheral systems of APP/PS1 mice. Our findings indicate that HSD induced minor weight gain, exacerbated glycemic dysregulation, attenuated leptin signaling in the DMH and VMH of APP/PS1 mice, and altered food-entrainable circadian rhythms during NF.
Our study is the first to suggest that HSD differentially affects leptin signaling in the hypothalamic nuclei of APP/PS1 and WT mice. This attenuation of leptin signaling in HSD APP/PS1 mice may be correlated with increased Aβ levels, an elevation of neuroinflammation, and increased non-cognitive impairment in AD. (H) The percentages of fat mass present in NCD WT mice (n = 8), NCD APP/PS1 mice (n = 10), HSD WT mice (n = 11), and HSD APP/PS1 mice (n = 10) were calculated. Data is expressed as mean ± SEM. Significant differences between groups were determined by one-way ANOVA followed by Bonferroni post-hoc tests, and are labeled using # (p <0.05). Levels of fasting leptin in NCD WT mice (n = 9, 9, 9) , NCD APP/PS1 mice (n = 9, 9, 8) , HSD WT mice (n = 9, 9, 7) , and HSD APP/PS1 mice (n = 9, 9, 6) were measured at 6, 12, and 28 weeks after dietary manipulation, respectively (A).
Figure Legends
Levels of LepRs in NCD WT mice (n = 9, 9, 9) , NCD APP/PS1 mice (n = 8, 9, 9) , HSD WT mice (n = 9, 9, 8) , and HSD APP/PS1 mice (n = 9, 8, 6) were measured at 6, 12, and 28 weeks after dietary manipulation, respectively (B).
Levels of leptin (C) and LepRs (D) in NCD WT mice (n = 7, 9, 6) , NCD APP/PS1 mice (n = 7, 7, 5), HSD WT mice (n = 9, 9, 9) , and HSD APP/PS1 mice (n = 5, 9, 5) for the non-fasting, fasting, and refeeding after fasting states, respectively, were measured after 20 weeks of dietary manipulations. (E) The cumulative energy intakes of NCD WT (n = 7), NCD APP/PS1 (n = 7), HSD WT (n = 9), and HSD APP/PS1 (n = 9) mice after an i.p. injection of leptin (Lep) or the vehicle were measured after 28 weeks of dietary manipulation. Data is expressed as mean ± SEM. Significant differences between groups were determined by one-way ANOVA followed by Bonferroni post-hoc tests, and are labeled using # (p <0.05). Schematic diagram of the food entrainment test that was used to examine the food-entrainable circadian rhythms of NCD WT, NCD APP/PS1, HSD WT, and HSD APP/PS1 mice. After 23 weeks of dietary manipulation, mice were recorded on the ALF day, the 9 th day of RF, and NF day. (B-D) The distance traveled in 24 h during the day of ALF, the 9 th day of RF, and the NF day of NCD WT mice (n = 15), NCD APP/PS1 mice (n = 12), HSD WT mice (n = 9), and HSD APP/PS1 mice (n = 11). The shaded period indicates that the feeding period spanned from 11:00-15:00 on the RF day (C) and that no food was given during this feeding period on the NF day (D). (E-G) The total distances traveled during 7:00-15:00 on the ALF day, the 9 th day of RF, and the NF day of NCD WT mice (n = 15), NCD APP/PS1 mice (n = 12), HSD WT mice (n = 9), and HSD APP/PS1 mice (n = 11) were compared. (H) The distances traveled during 9:00-10:00, 9:00-11:00, 9:00-12:00, and 9:00-13:00 periods of NCD WT mice (n = 15), NCD APP/PS1 mice (n = 12), HSD WT mice (n = 9), and HSD APP/PS1 mice (n = 11) were compared on the NF day. Data is expressed as mean ± SEM. Statistical differences between groups were determined by one-way ANOVA followed by Bonferroni post-hoc tests, and are labeled using # (p <0.05). 
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